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Abstract —The increase growth of health information systems 
has provided a significant way to deliver great change in medical 
domains. Up to this date, the majority of medical centres and 
hospitals continue to use manual approaches for determining the 
correct medication dosage for sickle cell disease. Such methods 
depend completely on the experience of medical consultants to 
determine accurate medication dosages, which can be slow to 
analyse, time consuming and stressful. The aim of this paper is to 
provide a robust approach to various applications of machine 
learning in medical domain problems. The initial case study 
addressed in this paper considers the classification of medication 
dosage levels for the treatment of sickle cell disease. This study 
base on different architectures of machine learning in order to 
maximise accuracy and performance. The leading motivation for 
such automated dosage analysis is to enable healthcare 
organisations to provide accurate therapy recommendations 
based on previous data. The results obtained from a range of 
models during our experiments have shown that a composite 
model, comprising a Neural Network learner, trained using the 
Levenberg-Marquardt algorithm, combined with a Random 
Forest learner, produced the best results when compared to other 
models with an Area under the Curve of 0.995. 
Keywords —Machine Learning Algorithm; Sickle Cell Disease; 
Real-time data;  Receiver Operating Characteristic Curve; The Area 
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I. INTRODUCTION 
 Sickle cell disease (SCD) is considered long-term disease 
that facing medical sector, affects human from early childhood. 
It has a high severe impact on the life expectancy and the 
patient’s quality of life due to red blood cells (RBCs) 
abnormality. This kind of disease affects the vast majority of 
patients suffering from genetic blood disorders, where the 
haemoglobin is measured as abnormal behaviour in the blood. 
The major cause for the disease within affected populations lies 
with a group of ancestral disorders that have resulted in a protein 
mutation inside the RBC called haemoglobin. The common 
symptoms of SCD are caused by the abnormality of 
haemoglobin, the major protein inside RBCs which carries 
oxygen from the lungs and passes it to the human body. The 
symptoms potentially lead to serious infections, damage to some 
organs, and tissue death. Normally, the shape of RBCs are 
flexible and circular, which gives them with more freedom to 
move through blood vessels. However, the RBCs with those 
who suffer from SCD may look like a crescent (C-shaped). 
Moreover, Crescent RBCs usually break down or die more 
quickly than normal RBCs, resulting in anaemia. 
 With respect to sickle cell disease, the most significant 
symptoms that could show effects on patients are shortness of 
breath, fatigue, headaches, and dizziness[1]. There are three 
major types of sickle cell disease. The first common one is called 
Hb SS, when patients inherit sickle cell genes from both parents 
[2]. The second is a disease is called Hb SC, the patient usually 
inherits the sickle cell gene (S) and the second gene (C), 
produced from an abnormal kind of haemoglobin [3]. Finally, in 
S-beta thalassemia, the patient inherits one gene of sickle cell 
and beta thalassemia can be inherited from anaemia. 
 Recent research has demonstrated the positive effects of a 
drug called hydroxyurea/hydroxycarbamide in terms of 
modifying the disease phenotype [4]. The clinical procedure to 
manage SCD modifying therapy is significantly time consuming 
and difficult for medical staff. In order to curtail the significant 
medical variability presented by such difficult crisis, healthcare 
consultants need to improve adherence to therapy, which is 
regularly poor and subsequently results in fewer benefits and 
elevated risks to patients.  
 Up to the present, the new trend of machine learning is 
becoming essential for the analysis of data within the medical 
domain.  This kind of techniques are being utilised in order to 
analysis the significance of healthcare factors in association with 
their integrations for prognosis, for instance, to overall patient 
management, for providing therapy and support, and the most 
important to predict the disease progression. [5].  
 The main objective of these enhancement is to develop the 
use of advanced technology in healthcare organisations [6]. 
Machine learning models have been developed and used to 
enhance medical decision support systems. Neural Network 
approaches is considerably used within classification techniques 
for medical fields. This is attributed to their features of parallel 
processing tools, self-organization, self-learning methods,  and 
non-linearity [7].  
 The rest of this paper is structured as follows. Section 2 
discusses the methodology of our experiments. Sections 3 
illustrates the complete results. Finally, Section 4 shows the 
conclusion and future work. 
II. METHODOLOGY 
     The most related work that shows in the field of machine 
learning architectures have been constrained  to predict and 
check the severe crises of sickle cell disease, rather than using 
advance predication to provide accurate amounts of 
hydroxyurea/hydroxycarbamide in modifying the disease 
phenotype [8]. Presently, there is no standardisation of disease 
modifying therapy management. Through using the proposed 
computerised comprehensive management system, the aim is to 
develop a reproducible and optimised standard of care in various 
clinical settings across the UK, and indeed internationally. The 
main aim of this research is to utilise recent advances in machine 
learning approaches, in order to support the healthcare 
professionals in giving accurate amounts of medication for each 
individual patient according to their medical conditions. In this 
case, and due to the pattern of the SCD dataset, this research 
attempts to propose classification of the patient’s data set records 
at an earlier stage, according to how much of a dose the patient 
will need to take. This can potentially avoid unnecessary 
admission to hospitals or special institutions, lower the costs 
significantly, mitigate patient illness before it gets worse over 
time, particularly with elderly people, unnecessary 
interventions, and to improve patient welfare. 
 There are different ways can obtain a better classification. 
Machine learning approaches can be applied to build strong 
integrated classifiers to use training and testing datasets, 
involving past patient observed cases that have been collected 
from the local hospital for Sickle Cell Disease in the city of 
Liverpool, UK, over the last ten years for 1168 patient records.   
A. Data Collection 
 The original datasets that are used in our study for SCD were 
gathered within a ten-year period. Datasets were simulated using 
real-life data sets provided by local hospital when patient takes 
blood test sample, which contains a set of datasets that used for 
checking patients’ condition. Each sample contains 12 features 
deemed important factors for predicting the SCD trait as showed 
in Table 1. These 12 features considered very important for SCD 
patients that clinicians mostly concentrate on to provide a 
suitable amount of medication dosage to tackle patient’s 
condition. In order to work with a large amount of data, a local 
hospital has supported this research with a number of patient 
records for the purpose of obtaining better services and 
accuracy. The resulting dataset comprised 1168 sample points, 
with a single target variable describing the 
hydroxyurea/hydroxycarbamide medication dosage in 
milligrams. To facilitate our classification study, the target 
dosage was discretised into 6 bins, denoted classes 1 through 6. 
It formed through dividing the output range (in Milligrams) into 
membership intervals of equal size: Class 1: [148 ≤ Y < 427mg], 
Class 2: [427 ≤ Y < 659mg], Class 3: [659 ≤ Y ≤ 937mg], Class 
4: [937 ≤ Y < 1201mg], Class 5: [1201 ≤ Y < 1453mg], Class 6: 
[1453 ≤ Y ≤ 1700mg]. 
TABLE I.    CHARACTERISTICS OF SCD DATASETS 
No Types of Attributes 
1 Weight 
2 Haemoglobin(Hb) 
3 Mean Corpuscular Volume (MCV) 
4 Platelets(PLTS) 
5 Neutrophils (white blood cell 
NEUT) 
6 Reticulocyte Count (RETIC A) 
7 Reticulocyte Count (RETIC %) 
8 Alanine aminotransferase (ALT) 
9 Body Bio Blood (BIO) 
10 Hb F 
11 Bilirubin (BILI) 
12 Lactate dehydrogenase (LDH) 
B. Experimental Setup  
 The models under study are composed of two types of 
integrated Machine learning algorithms: hybrid Neural Network 
with Levenberg-Marquardt learning algorithm [9], and Random 
Forest [9], combined using a further Levenberg neural network 
(H1), and hybrid Levenberg-Marquardt learning neural network 
and Random Forest, combined using Fischer discriminate 
analysis (H2). The competing model set is composed of a trained 
models using the Levenberg-Marquardt learning algorithm 
(LEVNN), a random forest classifier (RFC), Functional link 
neural network (FLNN) [10] and a Trainable decision tree 
Classifier (TREEC) [11]. Cross validation technique were used 
in these experiments for assessing how the outcomes of a 
statistical analysis could generalise to an independent datasets. 
The proportion of the datasets were divided into three part 
training, validation, and testing phase. This study used 10 fold-
cross validation to find an average percentage of the correct 
classifications. The training set received 70 %, validation set 
10%, while the testing set obtained 20% to estimate the accuracy 
and performance of the whole models. The main purpose of 
using cross validation is to avoid overfitting. In this context, this 
provides a great support, which indicate when more training is 
not producing optimal generalisation. However, the models 
can’t be overfitting due to the large number of datasets.  
 These models are considered to be strong non-linear 
classifiers and are appropriate to act as comparators of high 
accuracy and performance. The linear model used includes a 
linear transformation function with a single layer neural network 
at each class output unit. To obtain performance estimates for 
the respective models, this study ran each simulation 50 times 
and calculated the mean of the responses. The full set of models 
used in the experiments are described in Table 2. The random 
oracle model (ROM) is used to establish random case 
performance through the assignment of random responses for 
each class [12]. This study is based on multi-classes, which use 
6 classes to classify the amount of medication dosage as mention 
earlier in the data collection section. 
 
 
 
TABLE II.     CLASSIFICATION MODELS 
Models Description Architecture Training Algorithm Role 
ROM Random Oracle Model 
Pseudorandom 
number generator N/A 
Random 
Guessing 
Baseline 
LEVNN 
Levenberg-
Marquardt 
learning algorithm 
Context Units: 
One context unit 
for each output 
unit. 
Levenberg-
Marquardt 
Non-linear 
Compariso
n Model 
TREEC Trainable decision tree Classifier 
13 inputs, 3 
outputs 
Decision tree 
induction 
Non-linear 
Compariso
n Model 
RFC 
Random Forest, 
Decision Tree 
Ensemble 
Classifier 
Units: 13-30-3, 
tansig activations 
Random 
feature bagging 
Non-linear 
Compariso
n Model 
H1 
Levenberg-
Marquardt 
learning algorithm 
and Random 
Forest, combined 
using Levenberg 
neural network 
Hybrid 
Gradient 
descent with 
momentum and 
adaptive 
learning rate 
backpropagatio
n 
Test model 
H2 
Levenberg-
Marquardt 
learning neural 
network and 
Random Forest, 
combined using 
Fischer 
discriminate 
analysis   
Hybrid 
Gradient 
descent with 
momentum and 
adaptive 
learning rate 
backpropagatio
n 
Test model 
FLNN Functional link neural network  
Units: 13-30-3, 
tansig activations. 
Gradient 
descent with 
momentum and 
adaptive 
learning rate 
backpropagatio
n 
Test model 
LNN Linear Combiner Network 
Units: 13-3, linear 
activations 
Batch training 
with weight 
and bias 
learning rules 
Linear 
Compariso
n Model 
TABLE III.      PERFORMANCE METRIC CALCULATIONS 
Metric Name Calculation 
Sensitivity TP/(TP+FN) 
Specificity TN/(TN+FP) 
Precision TP/(TP+FP) 
F1 Score 2 * (Precision*Recall)/(Precision + Recall) 
Youden's J statistic (J Score) Sensitivity + Specificity − 1 
Accuracy (TP+TN)/(TP+FN+TN+FP) 
Area Under ROC Curve 
(AUC) 
0 <= Area under the ROC Curve <= 
1 
Our classifier evaluation involves sensitivity, specificity, 
precision, the F1 score, Youden’s J statistic, and whole 
classification performance and accuracy calculated as illustrated 
in Table 3.  Additionally, the classifiers were characterised using 
the Area under the Curve (AUC) and Receiver Operating 
Characteristic (ROC) plots and, where the classification 
capability through all functional points was determined. 
III. RESULTS 
 This section analyse the outcomes from the experiments as 
listed in Tables 4 and 5, showing results for training and testing 
of the classifiers, respectively. To clarify the results, this study 
provides further performance visualisations through the use of 
ROC plots (Figures 1 and 2) and the use of AUC comparison 
plots as illustrated in Figures 3 and 4. The results obtained from 
the experiments show that the chosen dataset exhibits significant 
non-linear relationships, presenting a challenge for the test 
models. Of the hybrid classifiers under study, the H2 
outperformed the H1 as shown in Table 5, demonstrating 
capability both in fitting the training data and also in 
generalising to unseen examples. The calculated means of AUCs 
for the H2 model, obtained for six classes during training yielded 
an area of 1 (ideal), in comparison to 0.995 over the test sample. 
Classes 1 to 6 were found to show excellent performance and 
consistent generalisation from the training to the test sets for this 
model. It was found that the LEVNN model, a standalone neural 
network, was able to compete with the composite models H1 and 
H2, yielding an average AUC of 0.991, slightly outperforming 
the H1 model and showing an overall rank of second place. The 
H1 model yielded an average AUC of 0.988, ranking third 
overall, outperforming the lower ranking models by a reasonable 
margin. All three of the top performing models, the H2, 
LEVNN, and H1, obtained nearly ideal AUCs and represent 
viable candidates for future use. 
 This research found that the classifiers FLNN, RFC, 
TREEC, constituted the next performance level obtained, with 
test AUCs of 0.972, 0.961, and 0.95 respectively. Of these three 
models, the FLNN model achieved the largest AUC, with results 
generalising reasonably from the training to the test set. In 
contrast, the RFC and TREEC models, both founded on decision 
tree primitives, produced an excellent fit to the training data 
while failing to generalise to the same degree for the test set, 
indicating that a degree of overfitting may have occurred. In fact, 
the TREEC performed ideally and the RFC near-ideally in terms 
of fitting to the training set, in contrast with the FLNN, which 
stopped short of an ideal fit, yet maintained consistent 
generalisation. Additionally, the three aforementioned models 
can be contrasted with the H2, LEVNN, and H1 models, which 
produced exceptional results in terms of both training and 
generalisation.  
 The average test of AUCs for this LNN ranged 0.849, which 
is seen to demonstrate performance significantly below that of 
the other models. The ROM is indicated to follow the diagonal 
of the ROC plots for all classes (see Figures 1 and 2), 
demonstrating by compare the importance of the outcomes from 
the rest of trained classifiers. This process of guessing yields 
both train and test set AUCs lower than the LNN trained model 
baseline. 
TABLE IV.   THE MEAN PERFORMANCE FOR CLASSIFIER (TRAINING) 
Model Sensitivity Specificity Precision F1 J Accuracy AUC 
ROM 0.493 0.542 0.179 0.253 0.0351 0.543 0.488 
LEVNN 1 1 1 1 1 1 1 
TREEC 1 1 1 1 1 1 1 
RFC 0.999 0.999 0.994 0.996 0.997 0.999 1 
H1 1 1 1 1 1 1 1 
H2 1 1 1 1 1 1 1
FLNN 0.954 0.964 0.809 0.873 0.918 0.963 0.985 
LNN 0.854 0.827 0.524 0.642 0.68 0.835 0.87 
 
 
 
 
TABLE V.   THE MEAN PERFORMANCE FOR CLASSIFIER (TESTING) 
Model Sensitivity Specificity Precision F1 J Accuracy AUC 
ROM 0.548 0.547 0.197 0.268 0.0949 0.539 0.524 
LEVNN 0.984 0.993 0.974 0.978 0.977 0.992 0.991 
TREEC 0.913 0.926 0.684 0.737 0.839 0.921 0.95 
RFC 0.892 0.918 0.648 0.741 0.81 0.915 0.961 
H1 0.977 0.995 0.98 0.978 0.971 0.992 0.988 
H2 0.989 0.99 0.94 0.961 0.979 0.989 0.995 
FLNN 0.95 0.966 0.803 0.862 0.916 0.962 0.972 
LNN 0.824 0.848 0.534 0.641 0.672 0.84 0.849 
 
Fig. 1.      ROC curve (Train) for classifiers 
 
Fig. 2.       ROC curve (Testing) for classifiers 
 
Fig. 3.     Train AUC per model 
 
Fig. 4.      Test AUC per model 
 Prior to proceeding to data modelling, the data representation 
was explored to investigate if any regularities could be 
uncovered within its structure. Additionally, the exploratory 
phase was used as a means of exposing any outliers and other 
questionable artefacts in the data if such defects were present, 
such that the results of later analysis would not be invalidated 
due to unsound input. Exploratory analysis is an important step 
in the machine learning approach, allowing the human advisor 
to gain an intuition of the data and also the potential learnability 
of such data. The results from data exploration can be used to 
guide the modelling phase, since a major component learnability 
is known to be a function of the correspondence between the 
learning algorithm and the type of representation it is supplied 
with. To undertake an exploration of the utilised data in these 
experiments, it is computed summary statistics, followed by 
visualisation methods including Stochastic Proximity 
Embedding (SPE), t-distributed Stochastic Neighbourhood 
Embedding (tSNE), and Principal Component Analysis (PCA) 
as reported in Figures 5, 6 and 7, respectively. Results from the 
visualisation procedures reveal that some discernible structure is 
present within the data. The PCA plot shows that there are 
possible clusters of values present within the data, a finding 
which is further elaborated through the tSNE plot, demonstrates 
that the data can be reasonably geometrically separated when 
considering various intervals of dosage level. Furthermore, the 
exploratory analysis shows no obvious defects that could call 
into question the results of subsequent analysis. 
 
Fig. 5.      SPE plot  
 
Fig. 6.    tSNE plot  
 
Fig. 7.    PCA plot 
IV. CONCLUSION 
     This study presents an experimental investigation into the 
use of different neural network algorithms to classify the level 
of dosage for SCD. In this paper, various model architectures 
are used for analysing the medical datasets obtained from SCD 
patients. The main purpose of this research is to examine the 
effectiveness of these models in terms of training and testing 
setting, investigating if such architectures could enhance 
classification results. It was discovered through experimental 
investigation, comprising the usage of patient sample data and 
approaches such as H1, H2, LEVNN and RFC, TREEC, and 
FLNN, that the analysis of medical data for the SCD objective 
is viable and yields precise results. The results obtained from a 
range of models during our experiments have shown that the 
proposed hybrid Levenberg-Marquardt learning neural network 
and Random Forest, combined using Fischer discriminate 
analysis (H2) generated significantly better outcomes over the 
other range of classifiers. The local hospital has supported this 
research with a more than 1100 sample examples for the 
purpose of obtaining better services and accuracy. Further 
research will be recommended to implement to make 
confirmation on our findings, where a large number of data 
could be utilised also to advance the performance of the results. 
This study has indicated only a certain number of neural 
networks architectures. In this circumstance, it is recommended 
however that a machine learning algorithms, for instance, 
ADABoost classifier and  Automatic neural network classifier 
could be used to increase the scale and scope of this research.  
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